arsenic trioxide has been researched along with Carcinoma, Ductal, Pancreatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Lin, L; Lin, X; Ou, G; Pan, L; Su, M; Tan, Y; Tian, Z | 1 |
| Aitbayev, C; Batyrbekov, K; Begimbetova, D; Burska, AN; Fazyl, F; Gulyayev, A; Khamijan, M; Kukanova, A; Makishev, A; Manekenova, K; Omarov, T; Saliev, T; Sarbassov, D; Spatayev, Z; Yermekbayeva, B | 1 |
| Dong, J; Hao, J; Huang, C; Lan, C; Lang, M; Li, X; Ren, H; Wang, H; Wang, X; Yang, S; Yang, Y; Yu, M | 1 |
3 other study(ies) available for arsenic trioxide and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis.
Topics: Apoptosis; Arsenic Trioxide; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Gemcitabine; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
The Oxidative Drug Combination for Suppressing KRAS G12D Inducible Tumour Growth.
Topics: Animals; Arsenic Trioxide; Ascorbic Acid; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Models, Animal; Drug Combinations; Humans; Mice; Oxidation-Reduction; Oxidative Stress; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras) | 2022 |
Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Binding Sites; Carcinoma, Pancreatic Ductal; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Forkhead Box Protein O1; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice, Nude; Mustard Compounds; Oxidative Stress; Oxides; Pancreatic Neoplasms; Phenylpropionates; Promoter Regions, Genetic; Reactive Oxygen Species; RNA Interference; Signal Transduction; Time Factors; Transcriptional Activation; Transfection; Xenograft Model Antitumor Assays | 2016 |